The Amyloidosis Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company). The supporters have no influence over the production of the content.
Welcome to The Amyloidosis Channel
Reporting from key international congresses and speaking with world-leading experts, VJHemOnc brings you the latest exciting advances in amyloidosis research, diagnosis and care. The Amyloidosis Channel delivers regular video interviews, roundtable discussions, podcasts and feature articles, so that you can keep up-to-date with all the practice-changing developments in amyloidosis.
Explore The Amyloidosis Channel to learn about the latest clinical trial updates, novel therapeutics and regimens, diagnostic advances and optimal management across all amyloidosis subtypes, including amyloid light chain (AL), amyloid A (AA), and transthyretin (ATTR) amyloidosis.